Atea Pharmaceuticals, Inc.

AVIR · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$64,696$143,823$646,709$764,375
Short-Term Investments$390,025$434,283$0$0
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$7,634$12,349$14,213$8,028
Total Curr. Assets$462,355$590,455$660,922$772,403
Property Plant & Equip (Net)$2,116$3,117$4,094$184
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$198$0
Tax Assets$0$0$0$0
Other NC Assets$197$1,396$1,494$305
Total NC Assets$2,313$4,513$5,786$489
Other Assets$0$0$0$0
Total Assets$464,668$594,968$666,708$772,892
Liabilities
Payables$4,458$4,252$2,551$4,534
Short-Term Debt$800$760$721$197
Tax Payable$0$0$99$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$13,345$27,364$15,107$52,152
Total Curr. Liab.$18,603$32,376$18,478$56,883
LT Debt$842$1,642$2,403$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$6,356$5,758$5,255$5,932
Total NC Liab.$7,198$7,400$7,658$5,932
Other Liabilities$0$0$0$0
Cap. Leases$1,642$2,402$3,124$197
Total Liabilities$25,801$39,776$26,136$62,815
Equity
Pref Stock$0$0$0$0
Common Stock$84$83$83$83
Retained Earnings-$364,220-$195,835-$59,879$56,030
AOCI$233$207-$684-$0
Other Equity$802,770$750,737$701,052$653,964
Total Equity$438,867$555,192$640,572$710,077
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$464,668$594,968$666,708$772,892
Net Debt-$63,054-$141,421-$643,585-$764,178